This article was last updated on April 16, 2022
Canada: 
Oye! Times readers Get FREE $30 to spend on Amazon, Walmart…
USA: Oye! Times readers Get FREE $30 to spend on Amazon, Walmart…
The Canadian market of generic erectile dysfunction drugs has now set completely open for business on Thursday by the Supreme Court of Canada as it annulled a Viagra patent owned by the pharmaceutical giant, Pfizer.
Only few hours after the ruling was passed, the rival company of Pfizer which had appealed the case in high court, Teva Canada, posted an alert on its website to announcing their own generic version of Viagra. This is the very first commercial competition to the Pfizer’s 14-year Viagra monopoly. The Supreme Court made the decision of annulling Pfizer’s Viagra patent with an outstanding support of 7-0 majority ruling, saying that the patent tried to “game” the Canadian system. Previously the high court had also ruled in favor of Teva Canada’s challenge of the legitimacy of the patent, paving the way for cheaper, generic versions.
Teva Canada did not give any comment on their victory so far, but their website clearly features a notice entitled, “Introducing Novo-Sildenafil,” a product it described as was “a generic alternative to Viagra.” An intellectual property expert at Montreal’s McGill University, Richard Gold, explained that “Canadian consumers will be saving money on it. There will probably be other generics involved soon enough.”
The ruling has cleared the Pfizer’s market monopoly of Viagra. The head office of the company in New York stated that “Pfizer expects to face generic competition in Canada shortly.” “Pfizer will continue to vigorously defend against challenges to its intellectual property.”
Be the first to comment